The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Hepatology. 2012 Jun;55(6):2005-23. doi: 10.1002/hep.25762.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Fatty Liver / diagnosis*
  • Fatty Liver / epidemiology
  • Fatty Liver / therapy*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Life Style
  • Metformin / therapeutic use
  • Non-alcoholic Fatty Liver Disease
  • Prevalence
  • Risk Factors
  • Thiazolidinediones / therapeutic use
  • Vitamin E / therapeutic use

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Thiazolidinediones
  • Vitamin E
  • Metformin